PTPRC and cancer: However, genomic evidence for the hybrid origin of these cells is still unavailable, leaving open other explanations: that CD45 is present due to aberrant gene expression, which is common in cancer, or that cancer cells acquire this protein through trogocytosis [81], a process that enables the intercellular exchange of membrane proteins [82], or by a similar phenomenon termed vampirization [83].